Unknown

Dataset Information

0

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.


ABSTRACT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, at the end of 2019, and there are currently no specific antiviral treatments or vaccines available. SARS-CoV-2 has been shown to use the same cell entry receptor as SARS-CoV, angiotensin-converting enzyme 2 (ACE2). In this report, we generate a recombinant protein by connecting the extracellular domain of human ACE2 to the Fc region of the human immunoglobulin IgG1. A fusion protein containing an ACE2 mutant with low catalytic activity is also used in this study. The fusion proteins are then characterized. Both fusion proteins have a high binding affinity for the receptor-binding domains of SARS-CoV and SARS-CoV-2 and exhibit desirable pharmacological properties in mice. Moreover, the fusion proteins neutralize virus pseudotyped with SARS-CoV or SARS-CoV-2 spike proteins in vitro. As these fusion proteins exhibit cross-reactivity against coronaviruses, they have potential applications in the diagnosis, prophylaxis, and treatment of SARS-CoV-2.

SUBMITTER: Lei C 

PROVIDER: S-EPMC7265355 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.

Lei Changhai C   Qian Kewen K   Li Tian T   Zhang Sheng S   Fu Wenyan W   Ding Min M   Hu Shi S  

Nature communications 20200424 1


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, at the end of 2019, and there are currently no specific antiviral treatments or vaccines available. SARS-CoV-2 has been shown to use the same cell entry receptor as SARS-CoV, angiotensin-converting enzyme 2 (ACE2). In this report, we generate a recombinant protein by connecting the extracellular domain of human ACE2 to the Fc region of the human immunoglobulin IgG1. A fusion protein containing an ACE2 mutant wi  ...[more]

Similar Datasets

| S-EPMC7744032 | biostudies-literature
| S-EPMC7523104 | biostudies-literature
| EMPIAR-11181 | biostudies-other
| S-BSST649 | biostudies-other
| EMPIAR-11180 | biostudies-other
| EMPIAR-11179 | biostudies-other
2024-02-17 | GSE255644 | GEO
| S-SCDT-EMM-2022-15904 | biostudies-other
| EMPIAR-11176 | biostudies-other
| EMPIAR-11177 | biostudies-other